TrialGut2022

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.

Raghav Sundar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.